Docoh
Loading...

BCDA BioCardia

BioCardia, Inc. operates as a clinical-stage regenerative medicine company. It develops novel therapeutics for cardiovascular diseases. The firm offers proprietary comprehensive biotherapeutic solutions for cardiovascular disease under the CardiAMP and CardiALLO brand. It operates in only one business segment, which is a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. The company was founded on January 12, 1994 and is headquartered in San Carlos, CA.

Company profile

Ticker
BCDA, BCDAW
Exchange
CEO
Peter Altman
Employees
Incorporated
Location
Fiscal year end
Former names
Cardo Medical, Inc., CLICKNSETTLE COM INC, NAM CORP, Tiger X Medical, Inc.
SEC CIK
IRS number
232753988

BCDA stock data

(
)

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

30 Mar 21
13 Apr 21
31 Dec 21
Quarter (USD)
Dec 20 Sep 20 Jun 20 Mar 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from BioCardia earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 21.41M 21.41M 21.41M 21.41M 21.41M 21.41M
Cash burn (monthly) (positive/no burn) (positive/no burn) 1.17M 1.29M 1.14M 1.03M
Cash used (since last report) n/a n/a 4.01M 4.45M 3.92M 3.54M
Cash remaining n/a n/a 17.39M 16.95M 17.49M 17.86M
Runway (months of cash) n/a n/a 14.9 13.1 15.4 17.3

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
31 Mar 21 Moyes Jay M Common Stock Grant Aquire A No No 0 3,456 0 54,267
31 Mar 21 Allen Jim L. Common Stock Grant Aquire A No No 0 2,520 0 681,722
31 Mar 21 Stertzer Simon H Common Stock Grant Aquire A No No 0 2,304 0 203,554
31 Mar 21 Blank Andrew Scott Common Stock Grant Aquire A No No 0 4,752 0 147,192
31 Mar 21 Krasno Richard M Common Stock Grant Aquire A No No 0 3,024 0 47,187

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

13F holders
Current Prev Q Change
Total holders 0 0
Opened positions 0 0
Closed positions 0 0
Increased positions 0 0
Reduced positions 0 0
13F shares
Current Prev Q Change
Total value 0 0
Total shares 0 0
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners
Shares Value Change
Largest transactions
Shares Bought/sold Change
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. junior Avg
New words: adipose, ahead, air, al, alter, alveoli, annum, answered, asymptomatic, bank, Biden, bloodstream, BSC, BSLF, cal, Cap, captioned, cartilage, carve, CCPA, Chhabria, combat, contingent, counter, cybersecurity, Dec, Diego, disagreement, disbursed, disbursement, elastic, energy, EUA, EXXclaim, factor, fat, feasibility, Flexibility, float, fluid, forgivable, forgiven, franchise, Funder, GDPR, genetic, genomic, ground, hand, hierarchical, hypoxemic, illegally, impeded, infection, inflammation, infusion, intravenously, Judge, Krisztina, LDT, Lender, lift, lifted, Lincoln, loan, LPC, MACCE, magnitude, mediator, migrate, moved, multipotent, mutate, nonhierarchical, onset, outreach, oxygen, Park, Paycheck, payroll, PKF, placement, plaintiff, PPP, precipitating, pro, proceeding, proliferation, prolonged, pulmonary, rata, reassigned, repay, rescission, resumed, resuming, risky, rulemaking, sensitive, Silicon, speculative, stroke, stromal, superseded, symptom, syndrome, tiny, trail, transmit, transseptal, unaudited, unbilled, unsecured, Valley, ventilatory, Vincent, vital, workforce, Zsebo
Removed: adaptation, aim, Allan, apparent, bedside, biologically, Black, burdensome, cancer, characterize, College, compensated, computing, conform, connective, copy, customary, de, dead, decade, deficiency, detail, differentiating, dissolution, easily, exchanged, excise, execute, facilitating, Fernandez, Fernando, fewer, field, finally, Georgia, head, highest, incorporating, injured, Integrated, intramyocardial, Jr, liquidate, listing, marker, medium, microcirculatory, modulation, optimized, percent, Pfenniger, predominantly, prepare, preserved, progenitor, realization, recommending, recreate, rendered, rental, reparative, reservoir, retrospectively, scenario, securely, signaling, sized, sourced, Stanford, surface, Tessler, transplanted, Trump, unearned, unrealized, vasculature, version, vessel, wall, Washington